Global Anti-infective Ophthalmic Preparation Market Growth 2022-2028
Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading.
The global market for Anti-infective Ophthalmic Preparation is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Anti-infective Ophthalmic Preparation market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Anti-infective Ophthalmic Preparation market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Anti-infective Ophthalmic Preparation market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Anti-infective Ophthalmic Preparation market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Anti-infective Ophthalmic Preparation players cover Novartis, Allergan, Harrow, Bausch Health and Santen, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Anti-infective Ophthalmic Preparation market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Anti-infective Ophthalmic Preparation market, with both quantitative and qualitative data, to help readers understand how the Anti-infective Ophthalmic Preparation market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Anti-infective Ophthalmic Preparation market and forecasts the market size by Type (Antibacterial, Antiviral and Antifungal), by Application (Hospital, Clinic, Household and Others), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Antibacterial
Antiviral
Antifungal
Anti-Parasitic
Others
Segmentation by application
Hospital
Clinic
Household
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Novartis
Allergan
Harrow
Bausch Health
Santen
Lupin Pharmaceuticals
Apotex
Akorn
Pfizer
Okogen
Fera Pharma
Chapter Introduction
Chapter 1: Scope of Anti-infective Ophthalmic Preparation, Research Methodology, etc.
Chapter 2: Executive Summary, global Anti-infective Ophthalmic Preparation market size (sales and revenue) and CAGR, Anti-infective Ophthalmic Preparation market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Anti-infective Ophthalmic Preparation sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Anti-infective Ophthalmic Preparation sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Anti-infective Ophthalmic Preparation market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Novartis, Allergan, Harrow, Bausch Health, Santen, Lupin Pharmaceuticals, Apotex, Akorn and Pfizer, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti-infective Ophthalmic Preparation Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Anti-infective Ophthalmic Preparation by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Anti-infective Ophthalmic Preparation by Country/Region, 2017, 2022 & 2028
2.2 Anti-infective Ophthalmic Preparation Segment by Type
2.2.1 Antibacterial
2.2.2 Antiviral
2.2.3 Antifungal
2.2.4 Anti-Parasitic
2.2.5 Others
2.3 Anti-infective Ophthalmic Preparation Sales by Type
2.3.1 Global Anti-infective Ophthalmic Preparation Sales Market Share by Type (2017-2022)
2.3.2 Global Anti-infective Ophthalmic Preparation Revenue and Market Share by Type (2017-2022)
2.3.3 Global Anti-infective Ophthalmic Preparation Sale Price by Type (2017-2022)
2.4 Anti-infective Ophthalmic Preparation Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Household
2.4.4 Others
2.5 Anti-infective Ophthalmic Preparation Sales by Application
2.5.1 Global Anti-infective Ophthalmic Preparation Sale Market Share by Application (2017-2022)
2.5.2 Global Anti-infective Ophthalmic Preparation Revenue and Market Share by Application (2017-2022)
2.5.3 Global Anti-infective Ophthalmic Preparation Sale Price by Application (2017-2022)
3 Global Anti-infective Ophthalmic Preparation by Company
3.1 Global Anti-infective Ophthalmic Preparation Breakdown Data by Company
3.1.1 Global Anti-infective Ophthalmic Preparation Annual Sales by Company (2020-2022)
3.1.2 Global Anti-infective Ophthalmic Preparation Sales Market Share by Company (2020-2022)
3.2 Global Anti-infective Ophthalmic Preparation Annual Revenue by Company (2020-2022)
3.2.1 Global Anti-infective Ophthalmic Preparation Revenue by Company (2020-2022)
3.2.2 Global Anti-infective Ophthalmic Preparation Revenue Market Share by Company (2020-2022)
3.3 Global Anti-infective Ophthalmic Preparation Sale Price by Company
3.4 Key Manufacturers Anti-infective Ophthalmic Preparation Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-infective Ophthalmic Preparation Product Location Distribution
3.4.2 Players Anti-infective Ophthalmic Preparation Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Anti-infective Ophthalmic Preparation by Geographic Region
4.1 World Historic Anti-infective Ophthalmic Preparation Market Size by Geographic Region (2017-2022)
4.1.1 Global Anti-infective Ophthalmic Preparation Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Anti-infective Ophthalmic Preparation Annual Revenue by Geographic Region
4.2 World Historic Anti-infective Ophthalmic Preparation Market Size by Country/Region (2017-2022)
4.2.1 Global Anti-infective Ophthalmic Preparation Annual Sales by Country/Region (2017-2022)
4.2.2 Global Anti-infective Ophthalmic Preparation Annual Revenue by Country/Region
4.3 Americas Anti-infective Ophthalmic Preparation Sales Growth
4.4 APAC Anti-infective Ophthalmic Preparation Sales Growth
4.5 Europe Anti-infective Ophthalmic Preparation Sales Growth
4.6 Middle East & Africa Anti-infective Ophthalmic Preparation Sales Growth
5 Americas
5.1 Americas Anti-infective Ophthalmic Preparation Sales by Country
5.1.1 Americas Anti-infective Ophthalmic Preparation Sales by Country (2017-2022)
5.1.2 Americas Anti-infective Ophthalmic Preparation Revenue by Country (2017-2022)
5.2 Americas Anti-infective Ophthalmic Preparation Sales by Type
5.3 Americas Anti-infective Ophthalmic Preparation Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-infective Ophthalmic Preparation Sales by Region
6.1.1 APAC Anti-infective Ophthalmic Preparation Sales by Region (2017-2022)
6.1.2 APAC Anti-infective Ophthalmic Preparation Revenue by Region (2017-2022)
6.2 APAC Anti-infective Ophthalmic Preparation Sales by Type
6.3 APAC Anti-infective Ophthalmic Preparation Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Anti-infective Ophthalmic Preparation by Country
7.1.1 Europe Anti-infective Ophthalmic Preparation Sales by Country (2017-2022)
7.1.2 Europe Anti-infective Ophthalmic Preparation Revenue by Country (2017-2022)
7.2 Europe Anti-infective Ophthalmic Preparation Sales by Type
7.3 Europe Anti-infective Ophthalmic Preparation Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anti-infective Ophthalmic Preparation by Country
8.1.1 Middle East & Africa Anti-infective Ophthalmic Preparation Sales by Country (2017-2022)
8.1.2 Middle East & Africa Anti-infective Ophthalmic Preparation Revenue by Country (2017-2022)
8.2 Middle East & Africa Anti-infective Ophthalmic Preparation Sales by Type
8.3 Middle East & Africa Anti-infective Ophthalmic Preparation Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-infective Ophthalmic Preparation
10.3 Manufacturing Process Analysis of Anti-infective Ophthalmic Preparation
10.4 Industry Chain Structure of Anti-infective Ophthalmic Preparation
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-infective Ophthalmic Preparation Distributors
11.3 Anti-infective Ophthalmic Preparation Customer
12 World Forecast Review for Anti-infective Ophthalmic Preparation by Geographic Region
12.1 Global Anti-infective Ophthalmic Preparation Market Size Forecast by Region
12.1.1 Global Anti-infective Ophthalmic Preparation Forecast by Region (2023-2028)
12.1.2 Global Anti-infective Ophthalmic Preparation Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Anti-infective Ophthalmic Preparation Forecast by Type
12.7 Global Anti-infective Ophthalmic Preparation Forecast by Application
13 Key Players Analysis
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Anti-infective Ophthalmic Preparation Product Offered
13.1.3 Novartis Anti-infective Ophthalmic Preparation Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Allergan
13.2.1 Allergan Company Information
13.2.2 Allergan Anti-infective Ophthalmic Preparation Product Offered
13.2.3 Allergan Anti-infective Ophthalmic Preparation Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Allergan Main Business Overview
13.2.5 Allergan Latest Developments
13.3 Harrow
13.3.1 Harrow Company Information
13.3.2 Harrow Anti-infective Ophthalmic Preparation Product Offered
13.3.3 Harrow Anti-infective Ophthalmic Preparation Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Harrow Main Business Overview
13.3.5 Harrow Latest Developments
13.4 Bausch Health
13.4.1 Bausch Health Company Information
13.4.2 Bausch Health Anti-infective Ophthalmic Preparation Product Offered
13.4.3 Bausch Health Anti-infective Ophthalmic Preparation Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Bausch Health Main Business Overview
13.4.5 Bausch Health Latest Developments
13.5 Santen
13.5.1 Santen Company Information
13.5.2 Santen Anti-infective Ophthalmic Preparation Product Offered
13.5.3 Santen Anti-infective Ophthalmic Preparation Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Santen Main Business Overview
13.5.5 Santen Latest Developments
13.6 Lupin Pharmaceuticals
13.6.1 Lupin Pharmaceuticals Company Information
13.6.2 Lupin Pharmaceuticals Anti-infective Ophthalmic Preparation Product Offered
13.6.3 Lupin Pharmaceuticals Anti-infective Ophthalmic Preparation Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Lupin Pharmaceuticals Main Business Overview
13.6.5 Lupin Pharmaceuticals Latest Developments
13.7 Apotex
13.7.1 Apotex Company Information
13.7.2 Apotex Anti-infective Ophthalmic Preparation Product Offered
13.7.3 Apotex Anti-infective Ophthalmic Preparation Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Apotex Main Business Overview
13.7.5 Apotex Latest Developments
13.8 Akorn
13.8.1 Akorn Company Information
13.8.2 Akorn Anti-infective Ophthalmic Preparation Product Offered
13.8.3 Akorn Anti-infective Ophthalmic Preparation Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Akorn Main Business Overview
13.8.5 Akorn Latest Developments
13.9 Pfizer
13.9.1 Pfizer Company Information
13.9.2 Pfizer Anti-infective Ophthalmic Preparation Product Offered
13.9.3 Pfizer Anti-infective Ophthalmic Preparation Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Pfizer Main Business Overview
13.9.5 Pfizer Latest Developments
13.10 Okogen
13.10.1 Okogen Company Information
13.10.2 Okogen Anti-infective Ophthalmic Preparation Product Offered
13.10.3 Okogen Anti-infective Ophthalmic Preparation Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Okogen Main Business Overview
13.10.5 Okogen Latest Developments
13.11 Fera Pharma
13.11.1 Fera Pharma Company Information
13.11.2 Fera Pharma Anti-infective Ophthalmic Preparation Product Offered
13.11.3 Fera Pharma Anti-infective Ophthalmic Preparation Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Fera Pharma Main Business Overview
13.11.5 Fera Pharma Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Anti-infective Ophthalmic Preparation Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Anti-infective Ophthalmic Preparation Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Antibacterial
Table 4. Major Players of Antiviral
Table 5. Major Players of Antifungal
Table 6. Major Players of Anti-Parasitic
Table 7. Major Players of Others
Table 8. Global Anti-infective Ophthalmic Preparation Sales by Type (2017-2022) & (K Units)
Table 9. Global Anti-infective Ophthalmic Preparation Sales Market Share by Type (2017-2022)
Table 10. Global Anti-infective Ophthalmic Preparation Revenue by Type (2017-2022) & ($ million)
Table 11. Global Anti-infective Ophthalmic Preparation Revenue Market Share by Type (2017-2022)
Table 12. Global Anti-infective Ophthalmic Preparation Sale Price by Type (2017-2022) & (US$/Unit)
Table 13. Global Anti-infective Ophthalmic Preparation Sales by Application (2017-2022) & (K Units)
Table 14. Global Anti-infective Ophthalmic Preparation Sales Market Share by Application (2017-2022)
Table 15. Global Anti-infective Ophthalmic Preparation Revenue by Application (2017-2022)
Table 16. Global Anti-infective Ophthalmic Preparation Revenue Market Share by Application (2017-2022)
Table 17. Global Anti-infective Ophthalmic Preparation Sale Price by Application (2017-2022) & (US$/Unit)
Table 18. Global Anti-infective Ophthalmic Preparation Sales by Company (2020-2022) & (K Units)
Table 19. Global Anti-infective Ophthalmic Preparation Sales Market Share by Company (2020-2022)
Table 20. Global Anti-infective Ophthalmic Preparation Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Anti-infective Ophthalmic Preparation Revenue Market Share by Company (2020-2022)
Table 22. Global Anti-infective Ophthalmic Preparation Sale Price by Company (2020-2022) & (US$/Unit)
Table 23. Key Manufacturers Anti-infective Ophthalmic Preparation Producing Area Distribution and Sales Area
Table 24. Players Anti-infective Ophthalmic Preparation Products Offered
Table 25. Anti-infective Ophthalmic Preparation Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Anti-infective Ophthalmic Preparation Sales by Geographic Region (2017-2022) & (K Units)
Table 29. Global Anti-infective Ophthalmic Preparation Sales Market Share Geographic Region (2017-2022)
Table 30. Global Anti-infective Ophthalmic Preparation Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Anti-infective Ophthalmic Preparation Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Anti-infective Ophthalmic Preparation Sales by Country/Region (2017-2022) & (K Units)
Table 33. Global Anti-infective Ophthalmic Preparation Sales Market Share by Country/Region (2017-2022)
Table 34. Global Anti-infective Ophthalmic Preparation Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Anti-infective Ophthalmic Preparation Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Anti-infective Ophthalmic Preparation Sales by Country (2017-2022) & (K Units)
Table 37. Americas Anti-infective Ophthalmic Preparation Sales Market Share by Country (2017-2022)
Table 38. Americas Anti-infective Ophthalmic Preparation Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Anti-infective Ophthalmic Preparation Revenue Market Share by Country (2017-2022)
Table 40. Americas Anti-infective Ophthalmic Preparation Sales by Type (2017-2022) & (K Units)
Table 41. Americas Anti-infective Ophthalmic Preparation Sales Market Share by Type (2017-2022)
Table 42. Americas Anti-infective Ophthalmic Preparation Sales by Application (2017-2022) & (K Units)
Table 43. Americas Anti-infective Ophthalmic Preparation Sales Market Share by Application (2017-2022)
Table 44. APAC Anti-infective Ophthalmic Preparation Sales by Region (2017-2022) & (K Units)
Table 45. APAC Anti-infective Ophthalmic Preparation Sales Market Share by Region (2017-2022)
Table 46. APAC Anti-infective Ophthalmic Preparation Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Anti-infective Ophthalmic Preparation Revenue Market Share by Region (2017-2022)
Table 48. APAC Anti-infective Ophthalmic Preparation Sales by Type (2017-2022) & (K Units)
Table 49. APAC Anti-infective Ophthalmic Preparation Sales Market Share by Type (2017-2022)
Table 50. APAC Anti-infective Ophthalmic Preparation Sales by Application (2017-2022) & (K Units)
Table 51. APAC Anti-infective Ophthalmic Preparation Sales Market Share by Application (2017-2022)
Table 52. Europe Anti-infective Ophthalmic Preparation Sales by Country (2017-2022) & (K Units)
Table 53. Europe Anti-infective Ophthalmic Preparation Sales Market Share by Country (2017-2022)
Table 54. Europe Anti-infective Ophthalmic Preparation Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Anti-infective Ophthalmic Preparation Revenue Market Share by Country (2017-2022)
Table 56. Europe Anti-infective Ophthalmic Preparation Sales by Type (2017-2022) & (K Units)
Table 57. Europe Anti-infective Ophthalmic Preparation Sales Market Share by Type (2017-2022)
Table 58. Europe Anti-infective Ophthalmic Preparation Sales by Application (2017-2022) & (K Units)
Table 59. Europe Anti-infective Ophthalmic Preparation Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Anti-infective Ophthalmic Preparation Sales by Country (2017-2022) & (K Units)
Table 61. Middle East & Africa Anti-infective Ophthalmic Preparation Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Anti-infective Ophthalmic Preparation Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Anti-infective Ophthalmic Preparation Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Anti-infective Ophthalmic Preparation Sales by Type (2017-2022) & (K Units)
Table 65. Middle East & Africa Anti-infective Ophthalmic Preparation Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Anti-infective Ophthalmic Preparation Sales by Application (2017-2022) & (K Units)
Table 67. Middle East & Africa Anti-infective Ophthalmic Preparation Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Anti-infective Ophthalmic Preparation
Table 69. Key Market Challenges & Risks of Anti-infective Ophthalmic Preparation
Table 70. Key Industry Trends of Anti-infective Ophthalmic Preparation
Table 71. Anti-infective Ophthalmic Preparation Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Anti-infective Ophthalmic Preparation Distributors List
Table 74. Anti-infective Ophthalmic Preparation Customer List
Table 75. Global Anti-infective Ophthalmic Preparation Sales Forecast by Region (2023-2028) & (K Units)
Table 76. Global Anti-infective Ophthalmic Preparation Sales Market Forecast by Region
Table 77. Global Anti-infective Ophthalmic Preparation Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Anti-infective Ophthalmic Preparation Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Anti-infective Ophthalmic Preparation Sales Forecast by Country (2023-2028) & (K Units)
Table 80. Americas Anti-infective Ophthalmic Preparation Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Anti-infective Ophthalmic Preparation Sales Forecast by Region (2023-2028) & (K Units)
Table 82. APAC Anti-infective Ophthalmic Preparation Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Anti-infective Ophthalmic Preparation Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Europe Anti-infective Ophthalmic Preparation Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Anti-infective Ophthalmic Preparation Sales Forecast by Country (2023-2028) & (K Units)
Table 86. Middle East & Africa Anti-infective Ophthalmic Preparation Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Anti-infective Ophthalmic Preparation Sales Forecast by Type (2023-2028) & (K Units)
Table 88. Global Anti-infective Ophthalmic Preparation Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Anti-infective Ophthalmic Preparation Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Anti-infective Ophthalmic Preparation Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Anti-infective Ophthalmic Preparation Sales Forecast by Application (2023-2028) & (K Units)
Table 92. Global Anti-infective Ophthalmic Preparation Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Anti-infective Ophthalmic Preparation Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Anti-infective Ophthalmic Preparation Revenue Market Share Forecast by Application (2023-2028)
Table 95. Novartis Basic Information, Anti-infective Ophthalmic Preparation Manufacturing Base, Sales Area and Its Competitors
Table 96. Novartis Anti-infective Ophthalmic Preparation Product Offered
Table 97. Novartis Anti-infective Ophthalmic Preparation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 98. Novartis Main Business
Table 99. Novartis Latest Developments
Table 100. Allergan Basic Information, Anti-infective Ophthalmic Preparation Manufacturing Base, Sales Area and Its Competitors
Table 101. Allergan Anti-infective Ophthalmic Preparation Product Offered
Table 102. Allergan Anti-infective Ophthalmic Preparation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 103. Allergan Main Business
Table 104. Allergan Latest Developments
Table 105. Harrow Basic Information, Anti-infective Ophthalmic Preparation Manufacturing Base, Sales Area and Its Competitors
Table 106. Harrow Anti-infective Ophthalmic Preparation Product Offered
Table 107. Harrow Anti-infective Ophthalmic Preparation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 108. Harrow Main Business
Table 109. Harrow Latest Developments
Table 110. Bausch Health Basic Information, Anti-infective Ophthalmic Preparation Manufacturing Base, Sales Area and Its Competitors
Table 111. Bausch Health Anti-infective Ophthalmic Preparation Product Offered
Table 112. Bausch Health Anti-infective Ophthalmic Preparation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 113. Bausch Health Main Business
Table 114. Bausch Health Latest Developments
Table 115. Santen Basic Information, Anti-infective Ophthalmic Preparation Manufacturing Base, Sales Area and Its Competitors
Table 116. Santen Anti-infective Ophthalmic Preparation Product Offered
Table 117. Santen Anti-infective Ophthalmic Preparation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 118. Santen Main Business
Table 119. Santen Latest Developments
Table 120. Lupin Pharmaceuticals Basic Information, Anti-infective Ophthalmic Preparation Manufacturing Base, Sales Area and Its Competitors
Table 121. Lupin Pharmaceuticals Anti-infective Ophthalmic Preparation Product Offered
Table 122. Lupin Pharmaceuticals Anti-infective Ophthalmic Preparation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 123. Lupin Pharmaceuticals Main Business
Table 124. Lupin Pharmaceuticals Latest Developments
Table 125. Apotex Basic Information, Anti-infective Ophthalmic Preparation Manufacturing Base, Sales Area and Its Competitors
Table 126. Apotex Anti-infective Ophthalmic Preparation Product Offered
Table 127. Apotex Anti-infective Ophthalmic Preparation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 128. Apotex Main Business
Table 129. Apotex Latest Developments
Table 130. Akorn Basic Information, Anti-infective Ophthalmic Preparation Manufacturing Base, Sales Area and Its Competitors
Table 131. Akorn Anti-infective Ophthalmic Preparation Product Offered
Table 132. Akorn Anti-infective Ophthalmic Preparation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 133. Akorn Main Business
Table 134. Akorn Latest Developments
Table 135. Pfizer Basic Information, Anti-infective Ophthalmic Preparation Manufacturing Base, Sales Area and Its Competitors
Table 136. Pfizer Anti-infective Ophthalmic Preparation Product Offered
Table 137. Pfizer Anti-infective Ophthalmic Preparation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 138. Pfizer Main Business
Table 139. Pfizer Latest Developments
Table 140. Okogen Basic Information, Anti-infective Ophthalmic Preparation Manufacturing Base, Sales Area and Its Competitors
Table 141. Okogen Anti-infective Ophthalmic Preparation Product Offered
Table 142. Okogen Anti-infective Ophthalmic Preparation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 143. Okogen Main Business
Table 144. Okogen Latest Developments
Table 145. Fera Pharma Basic Information, Anti-infective Ophthalmic Preparation Manufacturing Base, Sales Area and Its Competitors
Table 146. Fera Pharma Anti-infective Ophthalmic Preparation Product Offered
Table 147. Fera Pharma Anti-infective Ophthalmic Preparation Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 148. Fera Pharma Main Business
Table 149. Fera Pharma Latest Developments
List of Figures
Figure 1. Picture of Anti-infective Ophthalmic Preparation
Figure 2. Anti-infective Ophthalmic Preparation Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-infective Ophthalmic Preparation Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Anti-infective Ophthalmic Preparation Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Anti-infective Ophthalmic Preparation Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Antibacterial
Figure 10. Product Picture of Antiviral
Figure 11. Product Picture of Antifungal
Figure 12. Product Picture of Anti-Parasitic
Figure 13. Product Picture of Others
Figure 14. Global Anti-infective Ophthalmic Preparation Sales Market Share by Type in 2021
Figure 15. Global Anti-infective Ophthalmic Preparation Revenue Market Share by Type (2017-2022)
Figure 16. Anti-infective Ophthalmic Preparation Consumed in Hospital
Figure 17. Global Anti-infective Ophthalmic Preparation Market: Hospital (2017-2022) & (K Units)
Figure 18. Anti-infective Ophthalmic Preparation Consumed in Clinic
Figure 19. Global Anti-infective Ophthalmic Preparation Market: Clinic (2017-2022) & (K Units)
Figure 20. Anti-infective Ophthalmic Preparation Consumed in Household
Figure 21. Global Anti-infective Ophthalmic Preparation Market: Household (2017-2022) & (K Units)
Figure 22. Anti-infective Ophthalmic Preparation Consumed in Others
Figure 23. Global Anti-infective Ophthalmic Preparation Market: Others (2017-2022) & (K Units)
Figure 24. Global Anti-infective Ophthalmic Preparation Sales Market Share by Application (2017-2022)
Figure 25. Global Anti-infective Ophthalmic Preparation Revenue Market Share by Application in 2021
Figure 26. Anti-infective Ophthalmic Preparation Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Anti-infective Ophthalmic Preparation Revenue Market Share by Company in 2021
Figure 28. Global Anti-infective Ophthalmic Preparation Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Anti-infective Ophthalmic Preparation Revenue Market Share by Geographic Region in 2021
Figure 30. Global Anti-infective Ophthalmic Preparation Sales Market Share by Region (2017-2022)
Figure 31. Global Anti-infective Ophthalmic Preparation Revenue Market Share by Country/Region in 2021
Figure 32. Americas Anti-infective Ophthalmic Preparation Sales 2017-2022 (K Units)
Figure 33. Americas Anti-infective Ophthalmic Preparation Revenue 2017-2022 ($ Millions)
Figure 34. APAC Anti-infective Ophthalmic Preparation Sales 2017-2022 (K Units)
Figure 35. APAC Anti-infective Ophthalmic Preparation Revenue 2017-2022 ($ Millions)
Figure 36. Europe Anti-infective Ophthalmic Preparation Sales 2017-2022 (K Units)
Figure 37. Europe Anti-infective Ophthalmic Preparation Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Anti-infective Ophthalmic Preparation Sales 2017-2022 (K Units)
Figure 39. Middle East & Africa Anti-infective Ophthalmic Preparation Revenue 2017-2022 ($ Millions)
Figure 40. Americas Anti-infective Ophthalmic Preparation Sales Market Share by Country in 2021
Figure 41. Americas Anti-infective Ophthalmic Preparation Revenue Market Share by Country in 2021
Figure 42. United States Anti-infective Ophthalmic Preparation Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Anti-infective Ophthalmic Preparation Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Anti-infective Ophthalmic Preparation Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Anti-infective Ophthalmic Preparation Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Anti-infective Ophthalmic Preparation Sales Market Share by Region in 2021
Figure 47. APAC Anti-infective Ophthalmic Preparation Revenue Market Share by Regions in 2021
Figure 48. China Anti-infective Ophthalmic Preparation Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Anti-infective Ophthalmic Preparation Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Anti-infective Ophthalmic Preparation Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Anti-infective Ophthalmic Preparation Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Anti-infective Ophthalmic Preparation Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Anti-infective Ophthalmic Preparation Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Anti-infective Ophthalmic Preparation Sales Market Share by Country in 2021
Figure 55. Europe Anti-infective Ophthalmic Preparation Revenue Market Share by Country in 2021
Figure 56. Germany Anti-infective Ophthalmic Preparation Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Anti-infective Ophthalmic Preparation Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Anti-infective Ophthalmic Preparation Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Anti-infective Ophthalmic Preparation Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Anti-infective Ophthalmic Preparation Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Anti-infective Ophthalmic Preparation Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Anti-infective Ophthalmic Preparation Revenue Market Share by Country in 2021
Figure 63. Egypt Anti-infective Ophthalmic Preparation Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Anti-infective Ophthalmic Preparation Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Anti-infective Ophthalmic Preparation Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Anti-infective Ophthalmic Preparation Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Anti-infective Ophthalmic Preparation Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Anti-infective Ophthalmic Preparation in 2021
Figure 69. Manufacturing Process Analysis of Anti-infective Ophthalmic Preparation
Figure 70. Industry Chain Structure of Anti-infective Ophthalmic Preparation
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets